Germán
Bou Arévalo
Hospital Universitario La Paz
Madrid, EspañaPublications in collaboration with researchers from Hospital Universitario La Paz (22)
2024
-
Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial
The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385
2023
-
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 6, pp. 360-370
2022
-
Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults
Antibiotics, Vol. 11, Núm. 9
-
Justification for 24/7 clinical microbiology services
Enfermedades Infecciosas y Microbiologia Clinica
2021
-
Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain
Revista Espanola de Quimioterapia, Vol. 34, Núm. 6, pp. 639-650
-
Clinitest rapid COVID-19 antigen test for the diagnosis of SARS-CoV-2 infection: A multicenter evaluation study
Journal of Clinical Virology, Vol. 143
2018
-
Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain
International Journal of Antimicrobial Agents, Vol. 51, Núm. 3, pp. 511-515
-
Antibiotic selection in the treatment of acute invasive infections by pseudomonas aeruginosa: Guidelines by the Spanish society of chemotherapy
Revista Espanola de Quimioterapia, Vol. 31, Núm. 1, pp. 78-100
-
Comparison of Predictors and Mortality between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae
Infection Control and Hospital Epidemiology, Vol. 39, Núm. 6, pp. 660-667
-
Current aspects in sepsis approach. Turning things around
Revista Espanola de Quimioterapia, Vol. 31, Núm. 4, pp. 298-315
-
Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae
International Journal of Antimicrobial Agents, Vol. 52, Núm. 5, pp. 577-585
-
Reporting antimicrobial susceptibilities and resistance phenotypes in Acinetobacter spp: A nationwide proficiency study
Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 3, pp. 692-697
2017
-
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
The Lancet Infectious Diseases, Vol. 17, Núm. 7, pp. 726-734
-
Empiric Therapy with Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results from the INCREMENT Cohort
Clinical Infectious Diseases, Vol. 65, Núm. 10, pp. 1615-1623
-
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
International Journal of Antimicrobial Agents, Vol. 50, Núm. 5, pp. 664-672
2016
-
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae
Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 7, pp. 4159-4169
-
Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
Journal of Infection, Vol. 72, Núm. 2, pp. 152-160
-
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 6, pp. 1672-1680
2015
-
Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish society of infectious diseases and clinical microbiology
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 5, pp. 337.e1-337.e21
-
Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 5, pp. 338-341